Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
herpes zoster vaccine (Jiangsu gdk Biotechnology)
- Development stage
- Unknown
- Lead developer
- Jiangsu gdk Biotechnology
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
The herpes zoster vaccine developed by Jiangsu gdk Biotechnology is a prophylactic vaccine designed to prevent shingles (herpes zoster) in adults. It targets the varicella-zoster virus (VZV), which remains latent in the nervous system following a primary varicella infection. The vaccine is formulated as a live-attenuated virus preparation that works by inducing a protective immune response, specifically boosting VZV-specific cell-mediated immunity. This enhancement of the immune system helps to suppress the reactivation of the latent virus in the sensory ganglia, thereby preventing the clinical manifestation of shingles. While Jiangsu gdk Biotechnology is primarily known for its quadrivalent influenza vaccines, this shingles vaccine is a key component of its pipeline focused on viral diseases affecting the elderly population.
- Other names
- VZV vaccineshingles vaccinevaricella-zoster virus vaccineFreeze-dried Live Attenuated Herpes Zoster Vaccine
Beyond the preview
Go deeper on herpes zoster vaccine (Jiangsu gdk Biotechnology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on herpes zoster vaccine (Jiangsu gdk Biotechnology).